-
Article | 2023.09.18
Laveran Class (2023-2026)
Promotion PPU 2023-2026PhD studentMaster degree studiesLaboratoryPhD DirectorLab HeadPhD ProjectDoctoral schoolPPU studentsBARONE KristaNew York University, New York, United StatesMacrophages and Endothelial CellsOBINO DorianGOMEZ-PEDIGUERO ElisaRole of perivascular macrophages in physiology and pathologyBioSPC - ED 562ESCOBAR RODRIGUEZ MarianaUniversity of Groningen, the Netherlands and...
-
Document de presse | 2024.01.11
Professor Yasmine Belkaid takes office as President of the Institut Pasteur
The Institut Pasteur is pleased to announce that Professor Yasmine Belkaid took office as its new President on January 2, 2024. Her appointment, approved by the Board of Governors on March 29, 2023, marks the beginning of a six-year term as President of the Institut Pasteur.Professor Yasmine Belkaid is a renowned scientist whose research focuses on the relationship between microbes and the immune...
-
Événement | 2024.06.25
Pasteur Innov’ Day: Fundamentally Applied ! 2nd edition – June 25, 2024
After a first successful edition in 2022, Pasteur Innov’ Day will be back at the Institut Pasteur Conference Center on June 25, 2024 from 2 p.m to 6 p.m (followed by a drinks reception). This year’s goal is the same as last year : to demonstrate the potential of the Institut Pasteur's research and innovation continuum to industry players in the health sector (from startups and mid-caps to major...
-
Portrait | 2024.05.21
Philippe Bousso: harnessing immune responses to combat cancer
Philippe Bousso, an immunologist and technophile with insatiable curiosity, is constantly tackling new challenges in his efforts to combat cancer. Like the characters in the sci-fi film Fantastic Voyage, he and his team use cutting-edge in vivo technologies to observe the ways in which the immune system wages war on cancer cells. For Philippe, creativity and innovation pave the way for new...
-
Article | 2024.10.08
Karikó Class (2024-2027)
PhD studentMaster degree studiesLaboratoryPhD DirectorLab HeadPhD ProjectDoctoral schoolPPU classicALTAF FIGUEIREDO CarolinaInstituto Superior Técnico da Universidade de Lisboa, PortugalPathogenesis of Bacterial AnaerobesDUPUY BrunoDUPUY BrunoExploring biology of biofilm formation by Clostridioides difficile and its role in gut persistence and relapse of infectionBioSPC ED 562CERCIAT...
-
Article | 2020.08.13
The Institut Pasteur Innovation Accelerator
The main challenge for academics in the commercialization of important new discoveries is the technological development gap: the phase between inventions at an early stage and the stage that innovative technologies must reach to become viable and attractive candidates for licensing and commercialization.For high risk/high value products or for products with low commercial profitability, it is...
-
Portrait | 2025.05.22
Guilherme Dias de Melo, exploring the mysteries of long COVID
The Brazilian-born scientist has devoted his career to exploring the links between viral infections and the brain. He specializes in neurotropic viruses and is working to elucidate the infectious mechanisms underpinning the SARS-CoV-2 and rabies viruses. With a transcontinental background, a passion for science and a coherent approach to research challenges, Guilherme Dias de Melo is driven by an...
-
Article | 2025.10.02
Nitti Class (2025-2028)
PhD studentMaster degree studies LaboratoryPhD DirectorLab HeadPhD projectDoctoral schoolPPU studentsBONNETT Samatha JaneUniversity College London, London, United KingdomUnité Régulation spatiale des génomesKOSZUL RomainKOSZUL RomainOrigin of compartmentalization in eukaryotic genomesCdV ED 515CLABBY TylerNew York University, New York City, United StatesGroupe à 5 ans Diversité...
-
Document de presse | 2011.01.02
Hepatitis C : in 2011, a predictive marker for response to therapy
Scientists at Inserm and Institut Pasteur have performed biomarker discovery on patients being treated for chronic hepatitis C infection. Their work, published in The Journal of Clinical Investigation, demonstrates that the plasma levels of the protein IP-10 predict, prior to treatment initiation, the efficacy of treatment with pegylated-interferon and ribavirin. Based on these results, the...
-
Article | 2019.04.24
Dr Amy Kristine Bei to head a new 4-year research group on malaria in Dakar
A new 4-year research group (G4) is being set-up at the Institut Pasteur de Dakar and started in early February following the agreement signed between the Institut Pasteur and AUF (Agence universitaire de la francophonie) on 31 January 2019, in collaboration with the Yale School of Public Health. Entitled « Malaria Experimental Genetic Approaches and Vaccines », it will be led by...